PMDA — authorised 21 September 2018
- Marketing authorisation holder: Astellas Pharma Inc
- Status: approved
🇯🇵 Xospata in Japan
PMDA authorised Xospata on 21 September 2018
Marketing authorisation
Xospata in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Xospata approved in Japan?
Yes. PMDA authorised it on 21 September 2018.
Who is the marketing authorisation holder for Xospata in Japan?
Astellas Pharma Inc holds the Japanese marketing authorisation.